BioLineRx Ltd. - American Depositary Shares (BLRX)

0.00 0.00%
    15分钟延迟

    交易条款

    交易时间 (UTC)
    星期一: 11:00 - 00:00
    星期二 - 星期五: 00:00 - 00:30, 11:00 - 00:00
    星期六: 00:00 - 00:30

    关于

    BioLine RX Ltd is an Israel-based clinical-stage biopharmaceutical company focused on oncology. The Company is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The Company is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.

    http://www.biolinerx.com
    х
    风险警告: 在金融市场上交易存在风险。投资产品可能会升值也可能会贬值,投资者可能会损失所有的本金。在涉及有杠杆的产品时,损失可能会大于初始本金。在金融市场上交易的风险信息可以在此查看 全面风险披露
    联系我们暴跌